TY - JOUR
T1 - ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate use criteria for peripheral vascular ultrasound and physiological testing part I
T2 - Arterial ultrasound and physiological testing
AU - Mohler, Emile R.
AU - Gornik, Heather L.
AU - Gerhard-Herman, Marie
AU - Misra, Sanjay
AU - Olin, Jeffrey W.
AU - Zierler, R. Eugene
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2012/7/17
Y1 - 2012/7/17
N2 - The American College of Cardiology Foundation (ACCF), in partnership with key specialty and subspecialty societies, conducted a review of common clinical scenarios where noninvasive vascular testing (ultrasound and physiological testing) is frequently considered. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and results of studies examining the implementation of the original appropriate use criteria (AUC). The 159 indications in this document were developed by a diverse writing group and scored by a separate independent technical panel on a scale of 1 to 9, to designate appropriate use (median 7 to 9), uncertain use (median 4 to 6), and inappropriate use (median 1 to 3). A total of 255 indications (with the inclusion of surveillance timeframes) were rated. One hundred and seventeen indications were rated as appropriate, 84 were rated as uncertain, and 54 were rated as inappropriate. The AUC for peripheral vascular disease have the potential to impact physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of uncertain clinical scenarios facilitates identification of areas that would benefit from future research.
AB - The American College of Cardiology Foundation (ACCF), in partnership with key specialty and subspecialty societies, conducted a review of common clinical scenarios where noninvasive vascular testing (ultrasound and physiological testing) is frequently considered. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and results of studies examining the implementation of the original appropriate use criteria (AUC). The 159 indications in this document were developed by a diverse writing group and scored by a separate independent technical panel on a scale of 1 to 9, to designate appropriate use (median 7 to 9), uncertain use (median 4 to 6), and inappropriate use (median 1 to 3). A total of 255 indications (with the inclusion of surveillance timeframes) were rated. One hundred and seventeen indications were rated as appropriate, 84 were rated as uncertain, and 54 were rated as inappropriate. The AUC for peripheral vascular disease have the potential to impact physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of uncertain clinical scenarios facilitates identification of areas that would benefit from future research.
KW - ACCF Appropriate Use Criteria
KW - abdominal aortic aneurysm
KW - ankle-brachial index
KW - arterial physiological testing
KW - carotid artery disease
KW - duplex ultrasound
KW - mesenteric artery disease
KW - noninvasive testing
KW - noninvasive vascular laboratory
KW - peripheral artery disease
KW - peripheral vascular disease
KW - renal artery stenosis
UR - http://www.scopus.com/inward/record.url?scp=84863663154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863663154&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2012.02.009
DO - 10.1016/j.jacc.2012.02.009
M3 - Article
C2 - 22694840
AN - SCOPUS:84863663154
VL - 60
SP - 242
EP - 276
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 3
ER -